Effects of adrenergic blocking agents on basal and stimulated thyroid function.
D000067956:Adenylyl Cyclase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000242:Cyclic AMP / Q000096:biosynthesis; D004789:Enzyme Activation; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D010084:Oxidation-Reduction; D010646:Phentolamine / Q000494:pharmacology; D010743:Phospholipids / Q000096:biosynthesis; D011433:Propranolol / Q000494:pharmacology; D012756:Sheep; D013565:Sympatholytics / Q000494:pharmacology*; D013961:Thyroid Gland / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D013972:Thyrotropin / Q000494:pharmacology
D000067956:Adenylyl Cyclase Inhibitors; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010743:Phospholipids; D013565:Sympatholytics; D013972:Thyrotropin; D011433:Propranolol; D000242:Cyclic AMP; D005947:Glucose; D010646:Phentolamine